Search research articles
Contact Us
Filters
Showing results (31-40 of 69) with videos related to
Page
of 7
Sort By:
Lakartidningen
|
December 18, 1996
[Two therapeutic models in venous leg ulcers are compared: better results with optimized compression]
B Olofsson, K Ljunghall, K Nordin-Björklund, et al.
European Journal of Pain (London, England)
|
December 19, 2007
Do psychosocial factors predict disability and health at a 3-year follow-up for patients with non-acute musculoskeletal pain? A validation of the Orebro Musculoskeletal Pain Screening Questionnaire
A Westman, S J Linton, J Ohrvik, et al.
Environmental Science. Processes & Impacts
|
February 1, 2019
Surface characterization and chemical speciation of adsorbed iron(iii) on oxidized carbon nanoparticles
Ajith Pattammattel, Valerie J Leppert, Henry Jay Forman, et al.
Angiology
|
July 1, 1994
Effect of magnesium sulfate infusion on circulating levels of noradrenaline and neuropeptide-Y-like immunoreactivity in patients with primary Raynaud's phenomenon
J Leppert, U Myrdal, T Hedner, et al.
Journal of Biomolecular NMR
|
March 21, 2001
2D relayed anisotropy correlation NMR: characterization of the 13C' chemical shift tensor orientation in the peptide plane of the dipeptide AibAib
B Heise, J Leppert, H Wenschuh, et al.
Journal of Internal Medicine
|
May 1, 1995
Cold exposure increases cyclic guanosine monophosphate in healthy women but not in women with Raynaud's phenomenon
J Leppert, A Ringqvist, J Ahlner, et al.
Lancet (London, England)
|
November 11, 1995
Magnesium sulphate increases plasma noradrenaline and neuropeptide-Y-like immunoreactivity
J Leppert, U Myrdal, T Hedner, et al.
Cardiovascular Drugs and Therapy
|
December 1, 1993
Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls
J Leppert, H Nilsson, U Myrdal, et al.
Clinical Physiology (Oxford, England)
|
May 1, 1997
Plasma nitric oxide metabolite in women with primary Raynaud's phenomenon and in healthy subjects
A Ringqvist, J Leppert, U Myrdal, et al.
Disability and Rehabilitation
|
March 2, 2006
Quality of life and maintenance of improvements after early multimodal rehabilitation: a 5-year follow-up
A Westman, S J Linton, T Theorell, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 69) with videos related to
Sort By:
Page
of 7
Lakartidningen
|
December 18, 1996
[Two therapeutic models in venous leg ulcers are compared: better results with optimized compression]
B Olofsson, K Ljunghall, K Nordin-Björklund, et al.
European Journal of Pain (London, England)
|
December 19, 2007
Do psychosocial factors predict disability and health at a 3-year follow-up for patients with non-acute musculoskeletal pain? A validation of the Orebro Musculoskeletal Pain Screening Questionnaire
A Westman, S J Linton, J Ohrvik, et al.
Environmental Science. Processes & Impacts
|
February 1, 2019
Surface characterization and chemical speciation of adsorbed iron(iii) on oxidized carbon nanoparticles
Ajith Pattammattel, Valerie J Leppert, Henry Jay Forman, et al.
Angiology
|
July 1, 1994
Effect of magnesium sulfate infusion on circulating levels of noradrenaline and neuropeptide-Y-like immunoreactivity in patients with primary Raynaud's phenomenon
J Leppert, U Myrdal, T Hedner, et al.
Journal of Biomolecular NMR
|
March 21, 2001
2D relayed anisotropy correlation NMR: characterization of the 13C' chemical shift tensor orientation in the peptide plane of the dipeptide AibAib
B Heise, J Leppert, H Wenschuh, et al.
Journal of Internal Medicine
|
May 1, 1995
Cold exposure increases cyclic guanosine monophosphate in healthy women but not in women with Raynaud's phenomenon
J Leppert, A Ringqvist, J Ahlner, et al.
Lancet (London, England)
|
November 11, 1995
Magnesium sulphate increases plasma noradrenaline and neuropeptide-Y-like immunoreactivity
J Leppert, U Myrdal, T Hedner, et al.
Cardiovascular Drugs and Therapy
|
December 1, 1993
Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls
J Leppert, H Nilsson, U Myrdal, et al.
Clinical Physiology (Oxford, England)
|
May 1, 1997
Plasma nitric oxide metabolite in women with primary Raynaud's phenomenon and in healthy subjects
A Ringqvist, J Leppert, U Myrdal, et al.
Disability and Rehabilitation
|
March 2, 2006
Quality of life and maintenance of improvements after early multimodal rehabilitation: a 5-year follow-up
A Westman, S J Linton, T Theorell, et al.
Page
of 7